Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

NCT: NCT04505618 · RECRUITING

NCT IDNCT04505618
StatusRECRUITING
Start Date2019-10-01
Completion2027-09-01
SponsorJohns Hopkins University (OTHER)
First posted
Last updated

Brief Summary

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Frequently Asked Questions

What is Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease?

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease is a clinical trial registered under NCT04505618. Current status: RECRUITING.

What is the status of NCT04505618?

The current status of NCT04505618 (Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease) is: RECRUITING.

When did Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease start?

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease started on 2019-10-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.